Actemra Injection 162 Mg Price in Pakistan

Actemra Injection in Pakistan:

Actemra Injection in Pakistan Pakistani Actemra Injection An FDA-approved biological drug called Actemra (tocilizumab) is administered intravenously or subcutaneously to treat some patients with covid-19, rheumatoid arthritis, massive cellular arteritis, scleroderma, polyarticular or systemic juvenile idiopathic arthritis, and excessive cytokine release syndrome.

On December 21, 2022, Actrema became fda-approved for the treatment of covid-19 in certain adult patients. Actrema is still accessible to pediatric patients with covid-19 (aged 2 to 18 years) thanks to emergency use authorizations (eua).

A monoclonal antibody called Actemra Injection is available in Pakistan; it blocks the interleukin-6 (il-6) protein in your body.

Your immune system becomes overactive when this protein is activated. Which increases your risk of infection and the manifestations of autoimmune disease.

Actrema is hypothesized to block the interleukin-6 receptor. Which reduces infection and the signs and symptoms of autoimmune illnesses by preventing the immune system from becoming overactive.

Actrema’s mode of action (moa). Which is more complex is that it binds to the sil-6r and mil-6r il-6 receptors. A number of cells, including lymphocytes, fibroblasts, t- and b-cells, and monocytes, release the well-known pro-inflammatory cytokine interleukin-6.

Uses:

Interstitial lung disease associated with systemic sclerosis (SSC-ILD) affects patients with interstitial lung disease associated with systemic sclerosis to slow the rate of pulmonary feature loss.
Patients with polyarticular juvenile idiopathic arthritis (pjia) who are 2 years of age or older and have an active form of the disease.
Patients with systemic juvenile idiopathic arthritis (sjia) who are 2 years of age or older who have active sjia.

Benifits:

Cytokine release syndrome (crs) is a severe or life-threatening form of cytokine launch syndrome that affects adults and pediatric patients 2 years of age and older.
Adult patients receiving systemic corticosteroids while hospitalized with covid-19 may receive an injection if they also need extra oxygen. Invasive or non-invasive mechanical air wafting. or extracorporeal membrane oxygenation (ecmo).
Covid-19: emergency use authorization for pediatric patients (2 years old to less than 18 years old) who have covid-19 and who need supplemental oxygen. Non-invasive or invasive mechanical air flow, or ecmo while taking systemic corticosteroids. Available in Islamabad, Lahore, Karachi, and the entire country of Pakistan.